Department of Medical Genetics, China Medical University, Heping District, Shenyang, China.
BMC Cancer. 2010 Jun 19;10:306. doi: 10.1186/1471-2407-10-306.
14-3-3epsilon regulates a wide range of biological processes, including cell cycle control, proliferation, and apoptosis, and plays a significant role in neurogenesis and the formation of malignant tumours. However, the exact function and regulatory mechanism of 14-3-3epsilon in carcinogenesis have not been elucidated.
The expression of 14-3-3epsilon was assessed by RT-PCR and western blotting. The invasiveness and viability of Hep-2 cells were determined by the transwell migration assay and MTT assay, respectively. Cell cycle and apoptosis of Hep-2 cells were detected by flow cytometry.
The mRNA and protein expression of 14-3-3epsilon in larynx squamous cell carcinoma (LSCC) tissues were significantly lower than those in clear surgical margin tissues. Statistical analysis showed that the 14-3-3epsilon protein level in metastatic lymph nodes was lower than that in paired tumour tissues. In addition, the protein level of 14-3-3epsilon in stage III or IV tumours was significantly lower than that in stage I or II tumours. Compared with control Hep-2 cells, the percentages of viable cells in the 14-3-3epsilon-GFP and negative control GFP groups were 36.68 +/- 14.09% and 71.68 +/- 12.10%, respectively. The proportions of S phase were 22.47 +/- 3.36%, 28.17 +/- 3.97% and 46.15 +/- 6.82%, and the apoptotic sub-G1 populations were 1.23 +/- 1.02%, 2.92 +/- 1.59% and 13.72 +/- 3.89% in the control, negative control GFP and 14-3-3epsilon-GFP groups, respectively. The percentages of the apoptotic cells were 0.84 +/- 0.25%, 1.08 +/- 0.24% and 2.93 +/- 0.13% in the control, negative control GFP and 14-3-3epsilon-GFP groups, respectively. The numbers of cells that penetrated the filter membrane in the control, negative control GFP and 14-3-3epsilon-GFP groups were 20.65 +/- 1.94, 17.63 +/- 1.04 and 9.1 +/- 0.24, respectively, indicating significant differences among the different groups.
Decreased expression of 14-3-3epsilon in LSCC tissues contributes to the initiation and progression of LSCC. 14-3-3epsilon can promote apoptosis and inhibit the invasiveness of LSCC.
14-3-3epsilon 调节广泛的生物学过程,包括细胞周期控制、增殖和凋亡,并在神经发生和恶性肿瘤形成中发挥重要作用。然而,14-3-3epsilon 在致癌作用中的确切功能和调节机制尚未阐明。
通过 RT-PCR 和 Western blot 评估 14-3-3epsilon 的表达。通过 Transwell 迁移实验和 MTT 测定分别测定 Hep-2 细胞的侵袭和活力。通过流式细胞术检测 Hep-2 细胞的细胞周期和凋亡。
喉鳞状细胞癌 (LSCC) 组织中 14-3-3epsilon 的 mRNA 和蛋白表达明显低于切缘正常组织。统计学分析显示,转移性淋巴结中 14-3-3epsilon 蛋白水平低于配对肿瘤组织。此外,III 期或 IV 期肿瘤的 14-3-3epsilon 蛋白水平明显低于 I 期或 II 期肿瘤。与对照 Hep-2 细胞相比,14-3-3epsilon-GFP 和阴性对照 GFP 组的活细胞百分比分别为 36.68±14.09%和 71.68±12.10%。S 期的比例分别为 22.47±3.36%、28.17±3.97%和 46.15±6.82%,凋亡亚 G1 群体分别为 1.23±1.02%、2.92±1.59%和 13.72±3.89%在对照组、阴性对照 GFP 和 14-3-3epsilon-GFP 组中,凋亡细胞的百分比分别为 0.84±0.25%、1.08±0.24%和 2.93±0.13%。穿过滤膜的细胞数在对照组、阴性对照 GFP 和 14-3-3epsilon-GFP 组中分别为 20.65±1.94、17.63±1.04 和 9.1±0.24,表明各组之间存在显著差异。
LSCC 组织中 14-3-3epsilon 的表达下调促进 LSCC 的发生和发展。14-3-3epsilon 可促进凋亡并抑制 LSCC 的侵袭。